UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: September 16, 2022 4:15 P.M.
Form: S-3
CIK: 0001106838
Company Name: Sonnet BioTherapeutics Holdings, Inc.
File Number: 333-267171